BioSpace News Archive

KEPRO today announced that the company has been recognized internationally for creative marketing and communications.

The March of Dimes Database for Preterm Birth Research, announced today in the journal Scientific Data, is already one of the most important innovative new tools for collaborative research on preterm birth, which affects 15 million babies worldwide each year. Now it’s ready to become an engine of discovery, March of Dimes says.

Company launches new brand and website and celebrates 20 million medication order milestone

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET

Local entrepreneur and BrightStar Care of Roseville, California owner, Ignacio Cespedes, was recently recognized at the BrightStar Care national conference as the distinguished recipient of the company’s most prestigious award—2018 Franchisee of the Year.

Revenue increased 19% year over year to $8.1 million

STRATEC Consumables and Vortex BioSciences enter into a supply agreement for manufacturing a microfluidic chip for the VTX-1 Liquid Biopsy System.

Behavioral Health Group (BHG) is continuing its commitment of providing high quality treatment for opioid addiction in the state of Alabama with the addition of the BHG Cullman Treatment Center

The Rainwater Charitable Foundation, one of the largest independent funders of neurodegenerative disease (ND) research, announced today that it is launching the Rainwater Prize Program to encourage and reward scientific progress toward new treatments for neurodegenerative diseases related to the accumulation of tau protein in the brain.

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology company, announced today that it filed an Investigational New Drug Application (IND) with the FDA to move forward a radiotherapeutic drug, CTT1403, into human clinical trials for prostate cancer.